Delivery Order SPE2DB20D3103-SPE2DB22FP7Z3
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,560.70, is for the delivery of MULTIHANCE 529 MG/ML VIAL 20ML, a medical product. This award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC, valued up to $999,999,999.00,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at up to $2,866.50, is for the delivery of MULTIHANCE 529 MG/ML VIAL 20ML, a medical supply product. The contract is a Delivery Order type with a Firm Fixed Price pricing arrangement, and has an ultimate completion date of June 11, 2024. Amerisourcebergen Drug Corp's Corporate Office Division, which...
- This federal contract award is for the supply of MULTIHANCE 529 MG/ML VIAL 20ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,989.50 firm-fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves to provide a wide range of pharmaceutical...
- This federal contract award is for the delivery of Multihance 529 mg/ml vial, 10 ml, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of...
- This federal contract award is for the delivery of MULTIHANCE 529 MG/ML VIAL 10ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $14,541.00 and an ultimate completion date of July 27, 2023. This delivery order contract is a firm fixed-price arrangement. The contract was awarded on July 26,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of MULTIHANCE 529 MG/ML VIAL 20ML, a pharmaceutical product, with a potential value of $1,719.90 and a completion date of January 9, 2024. Amerisourcebergen Drug Corp, a for-profit organization, has a history of providing pharmaceutical products and medical supplies to...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $6,111.77 for MULTIHANCE 529MG/ML 5S, a contrast agent pharmaceutical product, by the Defense Logistics Agency's Medical Supply Chain on September 8, 2025. This firm fixed price, non-competitive set-aside delivery order is due for completion by October 3, 2025, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- This federal contract award, valued at $20,620.61, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for Amerisourcebergen to deliver a comprehensive...
- This federal contract award, valued at $1,195.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to supply a comprehensive range of pharmaceutical products...
- This federal contract award, valued at $27,976.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FP7Z3Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,488.20, is a delivery order for the supply of 4558370902 - MULTIHANCE 529 MG/ML VIAL 10ML. The contract has a firm fixed price and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which also does business as Amerisourcebergen. The company holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued at up to $999,999,999.00, as well as a smaller IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000. These IDCs enable the company to efficiently provide a comprehensive range of pharmaceutical products and medical supplies to support military, veteran, and other federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 9/7/22 |